In particular, the increased expression of CCL5 has been shown to correlate with better clinical outcomes in several cancers including thyroid cancer, lung cancer, ovarian cancer, and melanoma (Table 1) [55,56]. This evidence concerns the gene CCL5 and ovarian cancer.